long term aes in psma-trt
Published 3 years ago • 139 plays • Length 1:46Download video MP4
Download video MP3
Similar videos
-
3:07
psma-trt, 225ac-j591 and 177lu-psma i&t in mcrpc
-
3:50
psma pet imaging in defining mpc and understanding long-term dynamics and treatment implications
-
3:02
unanswered questions in psma-targeted radionuclide therapy
-
3:50
the role of psma pet in recurrent prostate cancer
-
35:05
psma and beyond psma for prostate cancer
-
7:52
does high psa levels = prostate cancer? | dr steven tucker
-
15:07
#prostatecancer: cure vs remission after treatment | #markscholzmd | #pcri
-
16:53
bone metastasis: diagnosis and scans | #markscholzmd #alexscholz #pcri
-
1:30
ai biomarker predicts benefit of long-term adt in prostate cancer
-
1:36
advances in psma-targeted therapy for prostate cancer
-
0:40
psma pet findings in 225ac-j591-treated patients with mcrpc
-
3:30
radionuclide conjugates 225ac-j591 and 177lu-psma-i&t for mcrpc
-
8:06
psa less than 0.01 - next steps, testosterone after hormone therapy | answering youtube comments #58
-
2:25
phase i trial of arx517, an anti-psma adc, in mcrpc
-
1:11
assessing the role of psma-pet promise nomograms in prostate cancer
-
0:57
real-world outcomes of 177lu-psma-617 in mcrpc
-
1:28
vision: 177lu-psma-617 in psma-positive mcrpc
-
49:38
psma pet, mri, and mpmri imaging for prostate cancer, explained by johan stranne md
-
3:56
vision: 177lu-psma-617 in psma-positive mcrpc
-
4:48
vision: lu-177-psma-617 in mcrpc
-
1:37
recent advances in mhspc: 177lu-psma-617, propel and biomarker-directed strategies
-
2:42
latest updates in psma imaging for prostate cancer